LON:CMS Communisis (CMS) Share Price, News & Analysis → Gold Mania (From Stansberry Research) (Ad) Free CMS Stock Alerts GBX 70.80 0.00 (0.00%) (As of 12/7/2018) Add Compare Share Share Today's Range 70.80▼ 70.8050-Day Range 70.80▼ 70.8052-Week Range 47▼ 73Volume6,014 shsAverage Volume697,198 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Communisis alerts: Email Address Ad Paradigm PressNever use this word on your phone (FBI could be watching)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...Watch my unredacted video about what I think is coming next right here About Communisis Stock (LON:CMS)Communisis plc, together with its subsidiaries, provides integrated marketing services in the United Kingdom and internationally. It creates engaging content and delivers it across various customer touch-points, such as digital, broadcast, and print channels. The Customer Experience segment engages in creating personal customer relationships across direct, digital, and social channels. This segment also provides mission-critical personalized communications services, including customer engagement, corporate video communications, specialized content, transactional, and regulatory communication services; and direct mail, cheques, statements, and inbound services. The Brand Deployment segment provides brand activation strategy, shopper marketing, marketing supply chain management, fulfilment, logistics, and point of sale procurement services. The company serves banks, insurance, retail and fast moving consumer goods, utilities, and public sector clients. Communisis plc was incorporated in 1994 and is headquartered in London, the United Kingdom.Read More CMS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CMS Stock News HeadlinesApril 20, 2024 | finance.yahoo.comCMS Energy Corporation (CMS)February 24, 2024 | health.usnews.comWhat Is Medicare: Coverage, Cost and EnrollmentMay 4, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.February 3, 2024 | forbes.comBest Content Management Software (CMS) Systems In Canada For February 2024December 30, 2023 | latimes.comNew weight-loss drugs are out of reach for millions of older Americans because Medicare won’t payDecember 29, 2023 | health.usnews.comMaine Medicare Advantage Plans with Part DDecember 29, 2023 | newsweek.comMedicare Companies 'Stealing' $140 Billion From Patients, Democrat SaysDecember 21, 2023 | health.usnews.comPennsylvania Medicare Prescription Drug Plans (Part D)May 4, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.December 19, 2023 | health.usnews.comNorth Carolina Medicare Advantage PlansDecember 15, 2023 | health.usnews.comIdaho Blue Cross of Idaho Insurance Company Medicare Advantage Plans with Part DDecember 14, 2023 | health.usnews.comOhio Medicare Advantage Plans with Part DDecember 7, 2023 | health.usnews.comTennessee Medicare Prescription Drug Plans (Part D)December 7, 2023 | health.usnews.comCalifornia Medicare Prescription Drug Plans (Part D)November 16, 2023 | usatoday.comDeadline for Medicare Open Enrollment is coming up. What you need to know to make it easyOctober 26, 2023 | investopedia.comWhat Is the Age for Medicare Eligibility?October 22, 2023 | health.usnews.comThe Cost of Medicare: Out-of-Pocket Costs You Should Expect to PayOctober 21, 2023 | health.usnews.comHow to Pick a Medigap PlanOctober 18, 2023 | forbes.comMedicare Advantage Plans By State: Coverage Based On Where You LiveOctober 11, 2023 | usatoday.comWant to get the most from Medicare? An expert shares key adviceOctober 5, 2023 | forbes.com5 Best Medicare Part D Providers: Reviewed In 2023October 4, 2023 | cnet.comMedicare Premium Costs Are Going Up in 2024. Here's How MuchSeptember 19, 2023 | forbes.comBest Medicare Supplement Plans In Florida For 2023September 12, 2023 | health.usnews.comHumana Medicare Advantage Plans with Part DSeptember 9, 2023 | forbes.comWhat Is Medicare Supplement (Medigap)? Coverage, Costs And EligibilitySeptember 2, 2023 | cbsnews.comBiden administration announces 10 drugs targeted for Medicare price negotiationAugust 23, 2023 | newsweek.comWhat You Should Know About Medicare Advantage Home VisitsSee More Headlines Receive CMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Communisis and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/08/2018Today5/03/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorBusiness Services Industry Marketing Services Sub-IndustryN/A Current SymbolLON:CMS CUSIPN/A CIKN/A Webwww.communisis.com Phone+44-20-73828950FaxN/AEmployees2,018Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Andy Blundell (Age 58)CEO, Member of the Exec. Board & Director Mr. Steve RawlinsCFO, Director & Member of Exec. BoardMr. David HerridgeMD of Customer Experience & Member of the Exec. BoardMr. Jon WellingsMD of Brand Deployment & Member of the Exec. BoardMr. Mark LewisGroup Shared Services Director & Member of the Exec. BoardKey Competitors16421 (MRM.L)LON:MRM21512 (SAT.L)LON:SAT41578029 (BT.L)LON:BT435793 (ACM.L)LON:ACM54323 (GLS.L)LON:GLSView All Competitors CMS Stock Analysis - Frequently Asked Questions How have CMS shares performed in 2024? Communisis' stock was trading at GBX 70.80 on January 1st, 2024. Since then, CMS shares have increased by 0.0% and is now trading at GBX 70.80. View the best growth stocks for 2024 here. How were Communisis' earnings last quarter? Communisis plc (LON:CMS) announced its quarterly earnings results on Thursday, March, 8th. The company reported $6.40 EPS for the quarter, meeting the consensus estimate of $6.40. The firm had revenue of $375.87 million for the quarter. What other stocks do shareholders of Communisis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Communisis investors own include NetPlay TV (NPT), Byotrol (BYOT), Amino Technologies (AMO), boohoo group (BOO), Rdi Reit (RDI), Pantheon Resources (PANR), Barclays (BARC), Barratt Developments (BDEV), Lloyds Banking Group (LLOY) and Pan African Resources (PAF). How do I buy shares of Communisis? Shares of CMS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:CMS) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldCould Your Accounts Be Frozen?Allegiance GoldAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingJeff Bezos Just Humiliated Elon MuskInvestorPlaceForget Nvidia. This is the future of AIPorter & CompanyThe asset beating inflation by 4xColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Communisis plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.